Stellate Ganglion Block for COVID-19-Parosmia
Official Title
Stellate Ganglion Block for the Treatment of COVID-19-Induced Parosmia: Double-Blinded, Placebo-Controlled Randomized Clinical Trial
Study Details
The purpose of the study is to evaluate the efficacy and safety of the stellate ganglion block procedure as potential treatment for COVID-19-induced smell distortion.
Principal Investigator
Nyssa Farrell, MD
IRB Number
202304090
Eligibility
Participants must be ages 18 to 70 living in the USA
Participants must have computer access and an email address
Participants must have persistent COVID-related parosmia (smell distortion)
Compensation is provided for time and effort (contact the study team for compensation amount).
Volunteer Information
For more information about this study, contact Volunteer for Health at:
- 314.362.1000
- rprstaff@wustl.edu